Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Ebola Quarantine Escapees Return

By Drug Discovery Trends Editor | August 18, 2014

Some of the people who fled an Ebola quarantine center in a Liberian slum when it was looted over the weekend are again under observation at a hospital Monday, a health official said.
 
Late Saturday, residents of Monrovia’s West Point slum attacked a quarantine center, where people were being monitored for possible infection with Ebola. The residents were angry that patients were brought to the holding center from other parts of Monrovia.
 
During the raid, up to 30 suspected Ebola patients fled, but at least some have now been brought to another hospital, Assistant Health Minister Tolbert Nyenswah said late Sunday. It was not clear how many of those who fled had been tracked down or how authorities were identifying them.
 
None of those who fled had been confirmed with Ebola and the process of screening them is continuing, Nyenswah said.
 
There are concerns that the raid could fuel the spread of Ebola in a slum where at least 50,000 people live. Police said the looters stole bloody sheets and mattresses, which could carry the infection.
 
Authorities have struggled to contain the spread of an Ebola outbreak in West Africa. So far, it has killed 1,145 of the more than 2,000 people sickened in Guinea, Liberia, Nigeria and Sierra Leone.
 
Ebola is spread through direct contact with bodily fluids and there is no licensed treatment. The only way to contain the disease is to isolate the sick and closely watch those they have come into contact with for signs of infection. 
 
Date: August 18, 2014
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
China’s biopharma sector enters ‘innovation 2.0’ era
The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE